Here, we report on the technical feasibility and safety of repeated percutaneous computed tomography (CT)–guided biopsy and intratumoral injections of Ad-CCL21-DC vaccine in patients with metastatic NSCLC. Here, CCL21 is linked to non-small cell lung carcinoma.